Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,665 | -85,474 | -55,135 | -31,955 | -27,749 |
| Depreciation Amortization | 339 | 1,934 | 1,740 | 1,351 | 699 |
| Accounts receivable | -2,805 | -3,301 | -9,619 | -8,016 | -2,479 |
| Other Working Capital | -11,645 | -12,924 | -15,758 | -9,783 | -4,179 |
| Other Operating Activity | 6,158 | 21,035 | 23,552 | 18,375 | 8,183 |
| Operating Cash Flow | $-34,618 | $-78,730 | $-55,220 | $-30,028 | $-25,525 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,708 | 128,750 | 84,327 | 63,151 | 33,474 |
| PPE Investments | N/A | -43 | -43 | -43 | -43 |
| Investing Cash Flow | $17,708 | $128,707 | $84,284 | $63,108 | $33,431 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 560 | 311 | 289 | 185 | 3 |
| Financing Cash Flow | $560 | $311 | $289 | $185 | $3 |
| Beginning Cash Position | 64,149 | 13,861 | 13,861 | 13,861 | 13,861 |
| End Cash Position | 47,799 | 64,149 | 43,214 | 47,126 | 21,770 |
| Net Cash Flow | $-16,350 | $50,288 | $29,353 | $33,265 | $7,909 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,618 | -78,730 | -55,220 | -30,028 | -25,525 |
| Capital Expenditure | N/A | -43 | -43 | -43 | -43 |
| Free Cash Flow | -34,618 | -78,773 | -55,263 | -30,071 | -25,568 |